Sulforaphane activates Nrf2 (nuclear factor erythroid 2-related factor 2) by modifying Keap1 — the protein that normally keeps Nrf2 locked in the cytoplasm. When sulforaphane modifies Keap1, Nrf2 is released, enters the nucleus, and switches on over 200 cytoprotective genes including: glutathione S-transferases (phase II detox), NAD(P)H quinone oxidoreductase (NQO1), heme oxygenase-1 (anti-inflammatory), and glutathione synthesis enzymes. This massive upregulation of cellular defenses is why sulforaphane shows benefits across such diverse conditions — it's not treating a specific disease, it's enhancing the body's fundamental protection systems.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.